Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment

详细信息    查看全文

• 作者：Wei Yu ; Fan Yang ; Jinghui Yang ; Lei Ma ; Yina Cun ; Shaohui Song and Guoyang Liao
• 刊名：Journal of Medical Virology
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：88
• 期：11
• 页码：1914-1921
• 全文大小：853K
• ISSN：1096-9071

文摘

Usage of influenza vaccine is the best choice measure for preventing and conclusion of influenza virus infection. Although it has been used of chicken embryo to produce influenza vaccine, following with WHO recommended vaccine strain, there were uncontrollable factors and its deficiencies, specially, during an influenza pandemic in the world. The Vero cells are used for vaccine production of a few strains including influenza virus, because of its homology with human, recommended by WHO. However, as known most of the influenza viruses strains could not culture by Vero cells. It was used two high-yield influenza viruses adapted in Vero cells as donor viruses, such as A/Yunnan/1/2005Va (H3N2) and B/Yunnan/2/2005Va (B), to construct high-yield wild influenza virus in Vero cells under antibody selection pressure. After reassortment and passages, it obtained the new Vaccine strains with A/Tianjin/15/2009Va (H1N1), A/Fujian/196/2009Va (H3N2) and B/Chongqing/1384/2010Va (B), which was not only completely keeping their original antigenic (HA and NA), but also grown well in Vero cells with high-yield. All results of gene analysis and HA, HI shown that this reassortment method could be used to find new direction to product the influenza vaccine. J. Med. Virol. 88:1914–1921, 2016.